Related references
Note: Only part of the references are listed.Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination
Mehmet Fethullah Aydin et al.
KIDNEY INTERNATIONAL (2021)
Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
Delphine Kervella et al.
KIDNEY INTERNATIONAL (2021)
IgG4-related disease: an update on pathophysiology and implications for clinical care
Cory A. Perugino et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients
Mikael Ebbo et al.
PLOS ONE (2017)
Share Paper
